WeVote
Log In

Bill

Bill

HB 3215

Relating to sponsorship of public charter schools.

2025 Regular Session Introduced by Emily McIntire

Creates a state regulatory framework for Illinois kratom products, requiring registration, testing, labeling, safety standards, and enforcement to protect consumers.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · HB 3215

Summary — HB 3215 (Illinois Kratom Consumer Protection Act)

Status: Introduced (Feb 18–24, 2025). In committee upon adjournment (6/28/2025). Primary sponsor: Rep. Marcus C. Evans, Jr.

Purpose

Creates the Illinois Kratom Consumer Protection Act to establish a state regulatory framework for kratom products (Mitragyna speciosa). The bill aims to set product limits, require product registration and testing, impose labeling and manufacturing standards, and authorize enforcement and penalties to promote consumer safety.

Key provisions

  • Definitions

    • Defines terms including “kratom,” “kratom extract,” “kratom product,” “registrant,” “retailer,” “distributor,” “independent testing laboratory” (ISO/IEC 17025 accreditation), “synthesized material,” and “attractive to children.”

  • Product limitations (prohibited or restricted products)

    • Caps 7‑hydroxymitragynine at no more than 2% of the alkaloid composition of a kratom product.
    • Prohibits products adulterated with poisonous/non‑kratom controlled substances.
    • Prohibits kratom products containing dangerous psychoactive compounds (e.g., synthetic cannabinoids/cathinones) or products mixed with substances that significantly inhibit CYP450 enzymes (CYP3A4, CYP2D6) unless specifically reviewed and permitted by the Department.
    • Bans combustible, vaporized, or injectable kratom forms.
    • Prohibits kratom products “attractive to children.”
    • Prohibits synthesized kratom alkaloids or artificially potentiated constituents unless manufacturer provides safety data supporting increased potency and label conditions of use.
    • Restricts kratom extracts to allowable residual solvent levels per the bill’s definition.

  • Registration and testing requirements

    • Parties placing kratom products into commerce in Illinois must register annually and pay fees to cover administrative costs.
    • Registrants of products subject to Section 10 must pay additional review fees to cover expert safety‑data reviews.
    • Registration must include sworn certifications (e.g., manufacturing in facilities complying with current good manufacturing practices consistent with 21 CFR 111).
    • Use of independent, ISO/IEC 17025‑accredited testing laboratories is specified for analysis.

  • Labeling and other requirements

    • The bill requires labeling requirements for kratom products (specific label details are referenced but not fully contained in the excerpt provided).

  • Exemptions and defenses

    • Processor exemption: a processor is exempt for kratom products that have been reviewed and approved by the Department for safe consumption in combination with psychoactive compounds under defined conditions.
    • Retailer defense: a retailer may be exempt if it proves by a preponderance of the evidence it relied in good faith on representations of certain entities.

  • Rulemaking and federal coordination

    • The Department of Financial and Professional Regulation is directed to adopt rules implementing the Act, with some rulemaking conditioned on federal regulation where specified.

  • Enforcement and penalties

    • The Act provides for enforcement mechanisms and both criminal and other penalties (details not fully excerpted).

Who is affected

  • Manufacturers/processors, distributors, registrants, and retailers of kratom products in Illinois.
  • Independent testing laboratories (accreditation expectations).
  • Consumers of kratom products.
  • The Department of Financial and Professional Regulation (rulemaking, oversight, review).
  • Entities providing safety data or representations used by retailers.

Procedural / timeline notes

  • Filed/introduced Feb 18–24, 2025; read first time and referred through various committees (Rules, Executive, Elections); read and re‑referred per legislative actions listed.
  • As of 2025‑06‑28 the bill is “in committee upon adjournment.”
  • Further action (committee hearings, amendments, votes) would be required before passage.

Note: Summary is based on the introduced version text provided; some sections in the excerpt are truncated or partially redacted, so certain technical details (complete label content, full certification language, and precise penalty descriptions) are not available here.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.